If you or someone you know is taking semaglutide and notices hearing problems, its important to speak with a healthcare provider and report the symptoms
Scientific Evidence So, what does the research actually tell us
Some laboratory studies have explored how this peptide may: These findings have positioned BPC-157 as a research focus in vascular biology , particularly in relation to circulatory adaptation and cellular oxygenation
Staying hydrated is also key
These may include: Nausea (affecting approximately 20-40% of patients, depending on the specific medication) [17] Mild abdominal discomfort or bloating Changes in bowel habits , including constipation or occasionally diarrhoea Reduced appetite , which whilst therapeutic, can feel unusual initially These effects are generally mild to moderate and tend to improve as the body adjusts to the medication, typically within 24 weeks
Participants were starting treatment with either GLP-1s or dipeptidyl peptidase-4 inhibitors (DPP4i), with 4,910 and 5,524 people in the respective cohorts